Tradestie Institutional Equity Comparison Engine

CNMD vs KTWO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CNMD Overall Edge

CNMD Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CONMED Corporation (CNMD) driven by superior Valuation, Growth & Margin, Options & Structure while KTWO counters with relative strength in Momentum & Technical. Fundamentally, CNMD trades at 9.8x Forward P/E with 10.2% operating margin (-0.7% YoY revenue) versus KTWO at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CNMD sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro) against KTWO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CNMD
CNMD 9.8x vs KTWO N/M Fwd P/E
Growth & Margin Winner CNMD
Op Margin 10.2% vs N/A ยท YoY -0.7% vs N/A
Momentum & Technical Winner KTWO
1Y +14.9% vs +2.5% ยท 52W Pos 65% vs 97%
Options & Structure Winner CNMD
CONSOLIDATION (2nd %ile IV) vs UNCLASSIFIED (N/A IV)
CNMD NYSE
CONMED Corporation
Electromedical & Electrotherapeutic Apparatus
$46.56
+0.39% 1D
Market Cap $1.4B
1M Return -5.83%
1Y Return +14.93%
Forward P/E 9.8x
Unified AI Score
49.1 / 100 HOLD
Tech 34.0 Fund 50.0 Flow 65.0 Mom 54.0
KTWO US Equity
KTWO
Institutional Equity
$10.12
-0.1% 1D
Market Cap N/A
1M Return +0.2%
1Y Return +2.53%
Forward P/E N/M
Unified AI Score
55.8 / 100 HOLD
Tech 66.0 Fund 57.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CNMD +14.93% KTWO +2.53% Spread: +1.66 pp (KTWO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CNMD TTM Op. Margin: 10.2% KTWO TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CNMD vs KTWO. Trailing 12-month operating profitability (CNMD 10.2% vs KTWO N/A) and valuation multiples (CNMD 9.8x vs KTWO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CNMD (7) vs KTWO (3)
Institutional Metric CNMD KTWO Criterion Row Winner
Market Capitalization Scale $1.4B N/A Larger Scale CNMD
Trailing P/E Ratio Valuation 19.2x N/M Lower Multiple CNMD
Forward P/E Ratio Valuation 9.8x N/M Lower Multiple CNMD
Revenue Growth (YoY) Growth -0.7% N/A Higher Growth CNMD
Operating Margin (TTM) Profitability 10.2% N/A Higher Margin CNMD
Net Profit Margin Profitability 5.4% N/A Higher Margin CNMD
Return on Equity (ROE) Capital Efficiency 7.1% N/A Higher ROE CNMD
52-Week Range Position Momentum 65% ($31โ€“$55) 97% ($10โ€“$10) Stronger Trend KTWO
Beta / 30D Volatility Risk Regime 0.82ฮฒ ยท 58% Vol 0.02ฮฒ ยท 4% Vol Lower Realized Risk KTWO
Unified Institutional Score Composite Signal 49.1 / 100 (HOLD) 55.8 / 100 (HOLD) Higher Composite KTWO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CNMD vs KTWO Buy Guide
CNMD CONSOLIDATION
78d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live CNMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KTWO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KTWO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CNMD nor KTWO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.